6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03321019 (ClinicalTrials.gov)	December 12, 2017	20/10/2017	Airway Protective Mechanisms in PD (R01)	Mechanisms of Airway Protection Dysfunction in Parkinson's Disease	Parkinson Disease	Drug: Capsaicin;Device: Resistive respiratory loads;Other: Event-related evoked potential using electroencephalography (EEG).;Procedure: Fluoroscopic swallow evaluation	University of Florida	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Recruiting	45 Years	85 Years	All	260		United States
2	NCT02390089 (ClinicalTrials.gov)	April 2015	19/2/2015	Cough According to Stimulus Type in PD	Airway Protection Deficits According to Stimulus Type in Parkinson's Disease	Parkinson's Disease	Drug: Capsaicin vapor;Other: fog;Radiation: Videofluoroscopic swallow evaluation;Device: Nebulizer	University of Florida	National Institute on Deafness and Other Communication Disorders (NIDCD)	Completed	50 Years	80 Years	All	158	Phase 1	United States
3	NCT02183519 (ClinicalTrials.gov)	October 2014	2/7/2014	Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease	Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease	Cough;Parkinson's Disease	Drug: Capsaicin;Other: Voluntary cough test	University of Florida	NULL	Completed	55 Years	85 Years	All	44	Phase 1/Phase 2	United States